Polypharmacy - we make it worse! A cross-sectional study from an acute admissions unit

Internal Medicine Journal

Volumn 42, Issue 2, 2012, Pages 208-211

  Betteridge, T M ^a   Frampton, C M ^a   Jardine, D L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Adverse drug reaction; Inappropriate prescribing; Polypharmacy

Indexed keywords

ADVERSE OUTCOME; AGED; ARTICLE; AUSTRALIA AND NEW ZEALAND; CROSS-SECTIONAL STUDY; FEMALE; GERIATRIC CARE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PHARMACEUTICAL CARE; POLYPHARMACY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; PATIENT ADMISSION; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY;

EID: 84857384939     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02690.x     Document Type: Article

References (20)

1. Gallagher PF, Barry P, Ryan C, Hartigan I, O'Mahony D. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing 2008; 37: 96-101.
2. Scott I, Jayathissa S. Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J 2010; 40: 7-18.
3. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the emergency department: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-50.
4. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870-4.
5. Barry M. Drug expenditure in Ireland 1991-2001. Ir Med J 2001; 95: 294-5.
6. Ashley-Jones C. National population projections 2009-2061. Statistics New Zealand 2009; 1-60.
7. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42: 1017-25.
8. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescribing is a leading cause. Drugs Aging 2005; 22: 767-77.
9. Gonski PN, Stathers GM, Freiman JS, Smith T. A critical review of admission and discharge medications in an elderly Australian population. Drugs Aging 1993; 3: 358-62.
10. Corsonello A, Pedone C, Corica F, Incalzi RA. Polypharmacy in elderly patients at discharge from the acute hospital. Ther Clin Risk Manag 2007; 3: 197-203.
11. Tulner LR, Kuper IM, van Campen JP, Koks CH, Brandjes DP, Beijnen JH. Discrepancies in reported drug use in geriatric outpatients: revelance to adverse events and drug-drug interventions. Am J Geriatr Pharmacother 2009; 7: 93-104.
12. Lau HS, Florax C, Porsius AJ, de Boer A. The completeness of medication histories in medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 2000; 49: 597-603.
13. Barry P, Gallager P, Ryan C, O'Mahony D. START [screening tool to alert doctors to right treatment]. An evidence-based screening tool to detect omissions in elderly patients. Age Ageing 2007; 36: 628-31.
14. Spinewine A, Swine C, Dhillon S, Franklin B, Tulkens P, Wilmotte L etal. Appropriateness of use of medicines in elderly inpatients; qualitative study. BMJ 2005; 331: 935-8.
15. Coleman E, Smith J, Raha D. Posthospital medication discrepancies and contributing factors. Arch Intern Med 2005; 165: 1842-7.
16. Campbell SE, Campbell MK, Grimshaw JM, Walker AE. A systematic review of discharge coding accuracy. J Public Health Med 2001; 23: 205-11.
17. Brvar M, Fokter N, Bunc M, Mozina M. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol 2009; 4: 9-18.
18. Beijer HUJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions [ADR]: a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
19. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 2010; 69: 543-52.
20. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H etal. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch Intern Med 2009; 169: 894-900.